NRx Pharmaceuticals Announces Final Clinical Trial Results; Believes Demonstration Of Reduced Akathisia In Setting Of Comparable Antidepressant Efficacy Constitutes Basis For Accelerated FDA Approval Of Nrx-101
nRx Pharmaceuticals公佈最終臨床試驗結果；認爲在抗抑鬱藥療效相似的情況下，證實靜坐不安情緒減少是美國食品藥品管理局加快批准Nrx-101的基礎